Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Novopharm

This article was originally published in The Tan Sheet

Executive Summary

Novopharm: Plans to launch nicotine gums for smoking cessation under an exclusive license with Premedent Technologies, a San Diego-based company specializing in chewing gum delivery systems. Pharmaceutical companies have expressed interest in a generic version of SmithKline Beecham's Nicorette as well as branded nicotine gums, and chain drug stores have inquired about store brand and private label versions, Toronto-based Novopharm notes. The firm plans to file an application with FDA for the nicotine gum in the third quarter and anticipates approval next year; Nicorette Waxman/Hatch exclusivity expires Feb. 9, 1999. Novopharm expects "revenues of about $100 mil. in the first year of launch from both licensing fees and a steady stream of royalties for nicotine gum alone." Other products in development include gums to administer medications to cancer patients, OTCs, and herbal and vitamin formulations...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088157

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel